CG
AUPH icon

Cutler Group’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cutler Group’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,400
Closed -$1K – 3764
2023
Q2 		$1K Sell
2,400
-11,500
-83% -$119K ﹤0.01% 3188
2023
Q1 		$8K Buy
+13,900
New +$122K ﹤0.01% 2430
2022
Q3 		– Sell
-6,500
Closed -$2K – 4890
2022
Q2 		$2K Sell
6,500
-60,300
-90% -$674K ﹤0.01% 4219
2022
Q1 		$22K Sell
66,800
-79,300
-54% -$1.23M ﹤0.01% 2951
2021
Q4 		$230K Buy
146,100
+36,800
+34% +$872K 0.01% 1205
2021
Q3 		$266K Buy
109,300
+94,400
+634% +$1.5M 0.01% 1171
2021
Q2 		$8K Buy
14,900
+13,900
+1,390% +$177K ﹤0.01% 4053
2021
Q1 		$1K Sell
1,000
-10,300
-91% -$149K ﹤0.01% 5123
2020
Q4 		$5K Buy
11,300
+1,900
+20% +$27.7K ﹤0.01% 3615
2020
Q3 		$3K Sell
9,400
-4,300
-31% -$62.3K ﹤0.01% 3779
2020
Q2 		$18K Sell
13,700
-1,000
-7% -$16K ﹤0.01% 2458
2020
Q1 		$23K Sell
14,700
-12,700
-46% -$224K ﹤0.01% 2195
2019
Q4 		$165K Buy
+27,400
New +$252K 0.01% 919
2019
Q2 		– Sell
-1,700
Closed -$3K – 4196
2019
Q1 		$3K Buy
1,700
+700
+70% +$4.64K ﹤0.01% 3154
2018
Q4 		$1K Sell
1,000
-4,800
-83% -$27.7K ﹤0.01% 3551
2018
Q3 		$8K Buy
5,800
+300
+5% +$1.68K ﹤0.01% 2762
2018
Q2 		$5K Buy
+5,500
New +$30.7K ﹤0.01% 3076
2018
Q1 		– Sell
-4,600
Closed -$1K – 4422
2017
Q4 		$1K Sell
4,600
-62,300
-93% -$346K ﹤0.01% 4362
2017
Q3 		$27K Sell
66,900
-35,600
-35% -$224K ﹤0.01% 2828
2017
Q2 		$63K Buy
102,500
+10,100
+11% +$68.1K ﹤0.01% 2267
2017
Q1 		$92K Buy
+92,400
New +$427K ﹤0.01% 1817

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cutler Group's AUPH Position: Q1 2024 in Review

Cutler Group sold out of Aurinia Pharmaceuticals (AUPH) in Q1 2024, closing a stake of 4,600 shares — an estimated $41K sold.

Cutler Group first reported a position in AUPH in Q4 2016 and held it in 25 quarters. The position peaked at $1.67M in Q4 2021. 179 funds tracked by Wall St. Rank hold AUPH as of Q1 2024.

  • Cutler Group reported no remaining Aurinia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 4,600 Aurinia Pharmaceuticals shares in Q1 2024, an estimated $41K.
  • Cutler Group first reported a position in Aurinia Pharmaceuticals in Q4 2016 and held it in 25 quarters.
  • Cutler Group's Aurinia Pharmaceuticals position peaked at $1.67M in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.